Zyprexa is Eli Lilly's top selling drug.
再普乐是礼来公司的最畅销的药物。
And in 2002, only 10 months after Lilly began selling Zyprexa in Japan, medical regulators in that country required Lilly to warn doctors against using Zyprexa in diabetic patients.
2002年,礼来的再普乐在日本上市仅10个月后,该国的卫生官员就要求礼来公司警告医师不要对糖尿病人开再普乐。
And in 2002, only 10 months after Lilly began selling Zyprexa in Japan, medical regulators in that country required Lilly to warn doctors against using Zyprexa in diabetic patients.
2002年,礼来的再普乐在日本上市仅10个月后,该国的卫生官员就要求礼来公司警告医师不要对糖尿病人开再普乐。
应用推荐